Ogawa Richard 4

What Happened Richard Ogawa, who serves as secretary and a director of Palomino Laboratories Inc., acquired 12,500 shares in an open‑market purchase on April 20, 2026 at $4.00 per share, for a total cost of $50,000. The transaction was reported on a Form 4 filed the same day.

Key Details

• Transaction date: 2026-04-20
• Transaction type/code: Open‑market purchase (Form 4 code P)
• Shares purchased: 12,500 at $4.00 per share
• Total value: $50,000
• Shares owned after transaction: Not disclosed in the provided filing excerpt
• Footnotes/plan: No 10b5‑1 plan or special conditions referenced in the provided excerpt
• Timeliness: Form 4 filed on 2026-04-20 (transaction date), indicating a timely report

Context This was a straight purchase by an officer/director rather than a sale or option exercise. Purchases by insiders can be more informative than routine sales, but the $50,000 size is relatively modest; use this data alongside other insider filings and company fundamentals when evaluating the stock.